Evecxia Therapeutics, Inc.—a clinical-stage neuroscience company developing a novel class of Serotonin Synthesis ...
New research suggests probiotics could help reduce "gastro bugs" in children attending childcare and ...
A new pancreatic cancer drug being tested by doctors is showing promise, potentially doubling survival rates for patients compared to chemotherapy alone.Related video above: Study finds pancreatic can ...
Gastroenterology continues to evolve rapidly as advances in colorectal cancer prevention, inflammatory bowel disease research, microbiome science and outpatient digestive care reshape the specialty.
Completed enrollment in first cohort of Phase 1b challenge study evaluating CDI-988 as a preventive and as a treatment for ...
Patient accrual complete for 1L HCC Phase 2 randomized clinical trial for anti-IL27 casdozokitug, timing for data readouts tracking to projections – – Tagmokitug, CCR8 Treg depleter development ...
Autoimmune gastritis (AIG) has been traditionally recognised as a precursor to type I gastric neuroendocrine tumours and ...
Objective: To compare the real-world effects of weekly injectable semaglutide (Ozempic) vs dulaglutide (Trulicity) on weight ...
A 45-reference UltraGene range, new respiratory panels and high-multiplex prototypes strengthen ABL Diagnostics ...
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from HERIZON-GEA-01 were published in The New England Journal of Medicine and will be ...
UCB, a global biopharmaceutical company, today announced Week 16 data from the BE BOLD trial demonstrating superior ACR50 joint outcomes at Week 16 for BIMZELX® (bimekizumab-bkzx) versus SKYRIZI® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results